mRNA therapy restores ureagenesis and corrects glutathione metabolism in argininosuccinic aciduria
biorxiv(2022)
摘要
Argininosuccinate lyase (ASL) is a key enzyme integral to the hepatic urea cycle which is required for ammonia detoxification, and the citrulline-nitric oxide (NO) cycle for NO production. ASL deficient patients present with argininosuccinic aciduria (ASA), an inherited metabolic disease with hyperammonaemia and a chronic systemic phenotype with neurocognitive impairment and chronic liver disease. ASL deficiency as an inherited model of systemic NO deficiency, shows enhanced nitrosative and oxidative stress. Here, we describe the dysregulation of glutathione biosynthesis and upstream cysteine utilization in ASL-deficient patients and mice using targeted metabolomics and in vivo positron emission tomography (PET) imaging using ( S )-4-(3-18F-fluoropropyl)-L-glutamate ([18F]FSPG). Upregulation of cysteine metabolism contrasted with glutathione depletion and down-regulated antioxidant pathways. hASL mRNA encapsulated in lipid nanoparticles corrected and rescued the neonatal and adult Asl-deficient mouse phenotypes, respectively, enhancing ureagenesis and glutathione metabolism and ameliorating chronic liver disease. We further present [18F]FSPG PET as a novel non-invasive diagnostic tool to assess liver disease and therapeutic efficacy in ASA. These findings support clinical translation of mRNA therapy for ASA.
### Competing Interest Statement
The work was partly funded by Moderna Therapeutics.
* ASA
: Argininosuccinic Aciduria
ASL
: Argininosuccinate Lyase
ASLD
: Argininosuccinate Lyase Deficiency
ASSD
: Argininosuccinate Synthase Ddeficiency
CyS
: Cysteine
CySS
: Cystine
GSH
: Glutathione
hASL
: human Argininosuccinate Lyase
HcyS
: Homocysteine
HcySS
: Homocysteine
HILIC
: Hydrophilic Interaction Liquid Chromatography
IP
: Intraperitoneal
IV
: Intravenous
IVIS
: In vivo imaging system
LNP
: Lipid nanoparticle
Luc
: Luciferase
MDA
: Malondialdehyde
NO
: Nitric Oxide
OTCD
: Ornithine Transcarbamylase Deficiency
PAS
: Periodic Acid Schaff
PET
: Positron Emission Tomography
ROI
: Regions of Interest
TBARS
: Thiobarbituric Acid reactive substances assay
WT
: Wildtype
xCT
: Cystine/Glutamate antiporter
[18F]FSPG
: (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate
更多查看译文
关键词
ureagenesis,glutathione metabolism,mrna therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要